Technological watch
Pharmco expands Brookfield packaging facility in US
Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.
Enter your details here to receive your free whitepaper.
Close survey Greenfield Global subsidiary and speciality alcohols producer Pharmco is expanding its Brookfield packaging facility in Connecticut, US, to grow its manufacturing expertise.The company will build a new bioprocessing wing, featuring aseptic filling function and temperature-controlled storage for stability programmes available from three to five years.Following the completion of the expansion, Pharmco will initially use the facility to assist its customers in outsourcing their resin storage, cleaning and regeneration solutions, as well as supporting key life science partners.The facility will produce packaging options, including single-use and rigid containers with sizes ranging from 1l bottles to 1,000l bags. The company will offer its stability programmes to customers upon request.
Pharmco sales and operations senior vice-president Steve DiBenedetto said: “We are proud of the role we are playing in helping advancements in bioprocessing, gene therapy and medical device industry by supplying high-quality, reliable pharmaceutical products.“Our customers do incredible things, and we will continue to focus our growth in areas that will deliver the maximum benefit to their work and specific needs.”The move is part of a series of Greenfield Global investments to expand the company’s expertise in manufacturing, storing and delivering speciality chemicals and ingredients to its global market.The company also announced plans to establish a new European manufacturing headquarters in Portlaoise, Ireland.Pharmco operates 12 distilled-spirit facilities to produce a range of speciality alcohols and bio-based chemicals for its international customers. Free WhitepaperSix essential ways to improve your pharmaceutical quality system Enter your details here to receive your free whitepaper.
Close survey Close
Enter your details here to receive your free whitepaper.
Close survey Greenfield Global subsidiary and speciality alcohols producer Pharmco is expanding its Brookfield packaging facility in Connecticut, US, to grow its manufacturing expertise.The company will build a new bioprocessing wing, featuring aseptic filling function and temperature-controlled storage for stability programmes available from three to five years.Following the completion of the expansion, Pharmco will initially use the facility to assist its customers in outsourcing their resin storage, cleaning and regeneration solutions, as well as supporting key life science partners.The facility will produce packaging options, including single-use and rigid containers with sizes ranging from 1l bottles to 1,000l bags. The company will offer its stability programmes to customers upon request.
Pharmco sales and operations senior vice-president Steve DiBenedetto said: “We are proud of the role we are playing in helping advancements in bioprocessing, gene therapy and medical device industry by supplying high-quality, reliable pharmaceutical products.“Our customers do incredible things, and we will continue to focus our growth in areas that will deliver the maximum benefit to their work and specific needs.”The move is part of a series of Greenfield Global investments to expand the company’s expertise in manufacturing, storing and delivering speciality chemicals and ingredients to its global market.The company also announced plans to establish a new European manufacturing headquarters in Portlaoise, Ireland.Pharmco operates 12 distilled-spirit facilities to produce a range of speciality alcohols and bio-based chemicals for its international customers. Free WhitepaperSix essential ways to improve your pharmaceutical quality system Enter your details here to receive your free whitepaper.
Close survey Close
This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.
